FDA Adverse Event Injury Summary report: N

U0308 XENIUM 210G SYNTH HFDIALYZER

MDR report key: 1251697 · Received December 2, 2008

Report

Report Number
1423500-2008-00956
Event Type
Injury
Date Received
December 2, 2008
Date of Event
November 15, 2008
Report Date
November 18, 2008
Manufacturer
NIPRO CORP
Product Code
KDI
PMA / PMN Number
K062079
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A REQUEST FOR THE RETURN OF THE SAMPLE HAS BEEN MADE. SHOULD THE SAMPLE BE RECEIVED FOR EVAL, A FOLLOW-UP REPORT WILL BE FILED UPON COMPLETION OF AN EVAL OR IF ANY ADDITIONAL INFO BECOMES AVAILABLE.

Description of Event or Problem · 1

THE ANTRIM AREA HOSP REPORTED HEMOLYSIS OCCURRED AFTER A PT RECEIVED HEMODIALYSIS USING A BAXTER XENIUM 210 DIALYZER IN 2008. A GAMBRO AK200 AND GAMBRO BLOODLINES BL225, LOT NUMBER 0850 WERE ALSO IN USE. THE ACID CONCENTRATE WAS BAXTER PRODUCT AND GAMBRO BICARBONATE CONCENTRATE WERE USED. THE PT WAS ON HEMODIALYSIS APPROX 20 MINUTES WHEN HE BECAME UNWELL, ANXIOUS, WITH PRESSURE SENSATION IN HEAD; EARS POPPING, SHIVERS, DECREASED TEMPERATURE AND ABDOMINAL PAIN (LOWER GROIN). A BLOOD PRESSURE OF 200/114 WAS MEASURED. THE SESSION WAS STOPPED AND THE SYMPTOMS RESOLVED AFTER FIVE MINUTES. THE PT'S BLOOD SAMPLES SHOWED EVIDENCE OF HEMOLYSIS. THE PT HAS BEEN USING A XENIUM DIALYZER FOR THREE WEEKS AND HAD NEVER EXPERIENCED A REACTION. THE DIALYZER WAS USED AS A DRY PACK (NOT REUSED). THE VASCULAR ACCESS WAS AN ARTERIO-VENOUS FISTULA PUNCTURED WITH A BAXTER SEOFLO FISTULA NEEDLE. THE PROGRAMMED ANTICOAGULATION WAS A BOLUS OF 1000 IU LITHIUM HEPARIN AT THE START OF THE DIALYSIS SESSION FOLLOWED BY 500 IU/HOUR. THE LINES WERE PRIMED WITH ONE LITER OF SALINE SOLUTION (MFR'S NAME, PRODUCT CODE AND LOT NUMBER UNK). THE THERAPY WAS PROGRAMMED FOR FOUR HOURS WITH A BLOOD FLOW RATE OF 390 ML/MIN AND AN ULTRA FILTRATION (UF) GOAL OF 0.7 LITERS. THE DIALYSIS SESSION STARTED AT 7:20 AM. NO UNTOWARD MACHINE ALARMS WERE REGISTERED DURING THE TREATMENT. NO LEAK WAS NOTICED DURING THE TREATMENT AND NO BLOOD LOSS HAS BEEN REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 U0308 XENIUM 210G SYNTH HFDIALYZER 78KDI KDI NIPRO CORP 08F05S

Patients

Seq Age Sex Outcome Treatment
1 53 YR Required Intervention PLATELETS COUNT DROPS TOO LOW| AZATHIOPRINE 150 MG FOR TWO DAYS WHEN HIS